Insider · CIK 0001317493

14159 capital (Gp), LLC

CIK 0001317493 Name as filed on the most recent filing

Filed as 14159 capital (Gp), LLC (180)· 14159 Capital (Gp, LLC (6)

642 transaction lines · from 186 filings · filed 2005-02-14 to 2012-03-14 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-28 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2008-06-05 P, Open-market purchase Genomic Health IncGHDX 2 lines 60,942, acquired Open Form 4 filing 0001144204-08-034278
2008-05-22 P, Open-market purchase Allos Therapeutics IncALTH 207,462, acquired Open Form 4 filing 0001144204-08-032229
2008-04-17 P, Open-market purchase Ardea Biosciences, Inc./DERDEA 11,925, acquired Open Form 4 filing 0001144204-08-023489
2008-04-04 P, Open-market purchase Ardea Biosciences, Inc./DERDEA 131,963, acquired Open Form 4 filing 0001144204-08-021203
2008-04-03 S, Open-market sale Tapestry Pharmaceuticals, IncTPPH 158, disposed Open Form 4 filing 0001144204-08-021221
2008-03-18 P, Open-market purchase Seattle Genetics Inc /WASGEN 13,420, acquired Open Form 4 filing 0001144204-08-016459
2008-03-17 P, Open-market purchase Seattle Genetics Inc /WASGEN 17,513, acquired Open Form 4 filing 0001144204-08-016459
2008-03-17 P, Open-market purchase Viropharma IncVPHM 1,473, acquired Open Form 4 filing 0001144204-08-015925
2008-03-14 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 31,668, acquired Open Form 4 filing 0001144204-08-015436
2008-03-14 P, Open-market purchase Viropharma IncVPHM 971, acquired Open Form 4 filing 0001144204-08-015925
2008-03-13 P, Open-market purchase Seattle Genetics Inc /WASGEN 9,661, acquired Open Form 4 filing 0001144204-08-015436
2008-03-13 P, Open-market purchase Viropharma IncVPHM 13,830, acquired Open Form 4 filing 0001144204-08-015925
2008-03-12 P, Open-market purchase Seattle Genetics Inc /WASGEN 2,889, acquired Open Form 4 filing 0001144204-08-015436
2008-02-25 P, Open-market purchase Allos Therapeutics IncALTH 16,194, acquired Open Form 4 filing 0001144204-08-012088
2008-02-21 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 23,653, acquired Open Form 4 filing 0001144204-08-011223
2008-02-20 P, Open-market purchase Allos Therapeutics IncALTH 13,376, acquired Open Form 4 filing 0001144204-08-011223
2008-02-19 P, Open-market purchase Allos Therapeutics IncALTH 13,770, acquired Open Form 4 filing 0001144204-08-011223
2008-02-11 P, Open-market purchase Seattle Genetics Inc /WASGEN 10,975, acquired Open Form 4 filing 0001144204-08-007634
2008-02-08 P, Open-market purchase Seattle Genetics Inc /WASGEN 2 lines 25,672, acquired Open Form 4 filing 0001144204-08-007634
2008-02-07 P, Open-market purchase Seattle Genetics Inc /WASGEN 7,371, acquired Open Form 4 filing 0001144204-08-007634
2008-01-23 P, Open-market purchase Seattle Genetics Inc /WASGEN 27,490, acquired Open Form 4 filing 0001144204-08-003617
2008-01-23 P, Open-market purchase Allos Therapeutics IncALTH 4,338, acquired Open Form 4 filing 0001144204-08-003626
2008-01-22 P, Open-market purchase Incyte CorpINCY 74, acquired Open Form 4 filing 0001144204-08-003838
2008-01-22 P, Open-market purchase Seattle Genetics Inc /WASGEN 18,292, acquired Open Form 4 filing 0001144204-08-003617
2008-01-22 P, Open-market purchase Allos Therapeutics IncALTH 131, acquired Open Form 4 filing 0001144204-08-003626
2008-01-18 P, Open-market purchase Seattle Genetics Inc /WASGEN 556,848, acquired Open Form 4 filing 0001144204-08-003617
2008-01-18 P, Open-market purchase Allos Therapeutics IncALTH 2 lines 2,134, acquired Open Form 4 filing 0001144204-08-003626
2008-01-15 P, Open-market purchase Allos Therapeutics IncALTH 4,650, acquired Open Form 4 filing 0001144204-08-002843
2008-01-14 P, Open-market purchase Incyte CorpINCY 12,097, acquired Open Form 4 filing 0001144204-08-002619
2008-01-14 P, Open-market purchase Allos Therapeutics IncALTH 21,110, acquired Open Form 4 filing 0001144204-08-002237
2008-01-11 P, Open-market purchase Allos Therapeutics IncALTH 9,005, acquired Open Form 4 filing 0001144204-08-002237
2008-01-11 P, Open-market purchase Incyte CorpINCY 10,641, acquired Open Form 4 filing 0001144204-08-001869
2008-01-10 P, Open-market purchase Allos Therapeutics IncALTH 18,942, acquired Open Form 4 filing 0001144204-08-002237
2008-01-10 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 169, disposed Open Form 4 filing 0001144204-08-002162
2008-01-10 P, Open-market purchase Incyte CorpINCY 440, acquired Open Form 4 filing 0001144204-08-001869
2008-01-09 P, Open-market purchase Allos Therapeutics IncALTH 9,522, acquired Open Form 4 filing 0001144204-08-001433
2008-01-09 P, Open-market purchase Viropharma IncVPHM 20,026, acquired Open Form 4 filing 0001144204-08-001585
2008-01-09 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 884, disposed Open Form 4 filing 0001144204-08-001410
2008-01-09 P, Open-market purchase Incyte CorpINCY 31,493, acquired Open Form 4 filing 0001144204-08-001869
2008-01-08 P, Open-market purchase Allos Therapeutics IncALTH 31,587, acquired Open Form 4 filing 0001144204-08-001433
2008-01-08 P, Open-market purchase Viropharma IncVPHM 28,669, acquired Open Form 4 filing 0001144204-08-001585
2008-01-08 P, Open-market purchase Incyte CorpINCY 2 lines 166,391, acquired Open Form 4 filing 0001144204-08-001236
2008-01-08 S, Open-market sale Idera Pharmaceuticals, Inc.IDP 39, disposed Open Form 4 filing 0001144204-08-001410
2008-01-07 P, Open-market purchase Allos Therapeutics IncALTH 15,008, acquired Open Form 4 filing 0001144204-08-001433

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. 14159 capital (GP), LLC, insider transactions. Retrieved 2026-08-28 from https://ebomi.com/insider/0001317493

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.